The incidence of cardiovascular diseases (CVD) in Asia-Pacific (APAC) is increasing and so is the demand for cardiac biomarker testing. More than half of the global CVD deaths in 2019 occurred in the region. Cardiac biomarkers play an increasingly important role in supporting timely, accurate diagnosis and management of acute coronary syndrome to prevent death.

The Middle East IVD market has mostly recovered to pre-pandemic levels. Without accounting for revenue for SARS-CoV-2 tests, the Middle East IVD market is expected to grow at an annual average of 2.5% from 2021 to 2026. 

The incidence of cardiovascular diseases (CVD) in Asia-Pacific (APAC) is increasing and so is the demand for cardiac biomarker testing. More than half of the global CVD deaths in 2019 occurred in the region. Cardiac biomarkers play an increasingly important role in supporting timely, accurate diagnosis and management of acute coronary syndrome to prevent death.

Thank you for requesting a free copy of the “Japan: The age of orthopaedic robotics surgery” report

With longer life expectancies in APAC, there is an increasing demand for knee replacement surgeries. From robotic platforms to computer navigation systems, discover how technology is improving procedures and expanding their uptake.

Thank you for requesting a free copy of the “Japan: The age of orthopaedic robotics surgery” report

With longer life expectancies in APAC, there is an increasing demand for knee replacement surgeries. From robotic platforms to computer navigation systems, discover how technology is improving procedures and expanding their uptake.

The incidence of cardiovascular diseases (CVD) in Asia-Pacific (APAC) is increasing and so is the demand for cardiac biomarker testing. More than half of global CVD deaths in 2019 occurred in the region. Cardiac biomarkers play an increasingly important role in supporting timely, accurate diagnosis and management of acute coronary syndrome to prevent death.

Instructions on how to join the session will be emailed to you shortly.

In this webinar, Clearstate will be centering the discussion on the global opportunities for China IVD companies. 在本次网络研讨会中，EIU Clearstate 将聚焦中国本土体外诊断公司的全球市场机遇。

Our medtech and life sciences consultancy has the capabilities to support your corporate and commercial needs. Uniquely, we bring together deep country and regional analysis, healthcare expertise and a variety of solutions designed to help you navigate dynamic markets, define your strategies and influence your customers. We augment our trusted advisory services with health policy, thought leadership and macro-economic country analysis.

In this webinar, Clearstate will be centering the discussion on how the IVD landscape in emerging markets has evolved post-pandemic, new focus areas for growth and the complex environment.